T 0239/16 (Zoledronic acid/NOVARTIS) of 13.9.2017

European Case Law Identifier: ECLI:EP:BA:2017:T023916.20170913
Date of decision: 13 September 2017
Case number: T 0239/16
Application number: 05012711.7
IPC class: A61K 31/663
A61P 19/08
A61P 19/10
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 589 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Method of administering bisphosphonates
Applicant name: Novartis AG
Novartis Pharma GmbH
Opponent name: Generics [UK] Limited
Sanovel Ilaç Sanayi ve Ticaret A.S.
Taylor Wessing LLP
Board: 3.3.01
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54(2)
European Patent Convention Art 56
Rules of procedure of the Boards of Appeal Art 12(1)
Rules of procedure of the Boards of Appeal Art 12(4)
Rules of procedure of the Boards of Appeal Art 13(1)
Keywords: Public availability of document (yes)
Main and auxiliary request: novelty - (yes)
Main and auxiliary request: inventive step - (no)
Catchwords:

-

Cited decisions:
T 0158/96
T 1081/01
T 0715/03
T 0293/07
T 1859/08
T 1057/09
T 2506/12
T 0895/13
T 1125/13
Citing decisions:
T 0844/18

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t160239eu1.html

Date retrieved: 17 May 2021

13 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: I Patentability

Case Law Book: V Priority

General Case Law